Undergoing Analysis
CVE has been recently published to the CVE List and has been received by the NVD.
CVE has been recently published to the CVE List and has been received by the NVD.
Products
Drug
- 1.0
Source
cve@mitre.org
Tags
CVE-2024-44837 details
Published : Sept. 6, 2024, 2:15 p.m.
Last Modified : Sept. 6, 2024, 4:46 p.m.
Last Modified : Sept. 6, 2024, 4:46 p.m.
Description
A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.
CVSS Score
| 1 | 2 | 3 | 4 | 5.4 | 6 | 7 | 8 | 9 | 10 |
|---|
Weakness
| Weakness | Name | Description |
|---|---|---|
| CWE-79 | Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') | The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. |
CVSS Data
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
Scope
CHANGED
Confidentiality Impact
LOW
Integrity Impact
LOW
Availability Impact
NONE
Base Score
5.4
Exploitability Score
2.3
Impact Score
2.7
Base Severity
MEDIUM
Vector String : CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
References
| URL | Source |
|---|---|
| https://kaput-raptorex-7c1.notion.site/drug-1-0-DOM-based-cross-site-scripting-fae620f769304f67a7488a961d048672 | cve@mitre.org |
This website uses the NVD API, but is not approved or certified by it.